ATX code
H05BA.
Used in the treatment of
- C41 Malignant neoplasm of bone and articular cartilage of other and unspecified sites
- E83.3.0* Hyperphosphatemia
- E83.5.0* Hypercalcemia
- M81.8.0* Senile osteoporosis
- C90.0 Multiple myeloma
- E05.9 Thyrotoxicosis, unspecified
- E21 Hyperparathyroidism and other disorders of parathyroid gland
- E67.3 Hypervitaminosis D
- E83.5 Disorders of calcium metabolism
- G56.4 Causalgia
- K05.4 Periodontosis
- K85 Acute pancreatitis
- M53.1 Cervicobrachial syndrome
- M53.8 Other specified dorsopathies
- M62.3 Immobility syndrome (paraplegic)
- M75.0 Adhesive capsulitis of shoulder
- M81.0 Postmenopausal osteoporosis
- M81.2 Osteoporosis of disuse
- M81.4 Drug-induced osteoporosis
- M81.8 Other osteoporosis
- M81.9 Osteoporosis, unspecified
- M84.1 Nonunion of fracture [pseudarthrosis]
- M85.0 Fibrous dysplasia (monostotic)
- M86.9 Osteomyelitis, unspecified
- M87.9 Osteonecrosis, unspecified
- M88 Paget's disease of bone [osteitis deformans]
- M89.0 Algoneurodystrophy
- M89.5 Osteolysis
- M89.8 Other specified disorders of bone
- M89.9 Disorder of bone, unspecified
- M90.8 Osteopathy in other diseases classified elsewhere
- N95.1 Menopausal and female climacteric states
- Q78.0 Osteogenesis imperfecta
- T14.2 Fracture of unspecified body region
- T45.2 Poisoning, vitamins, not elsewhere classified